Yi Lin

South China Agricultural University — China

Medicine · Health Sciences

78h-index38.0kcitations1.0kworks3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(337), Multiple Myeloma Research and Treatments(220), Lymphoma Diagnosis and Treatment(95), Amyloidosis: Diagnosis, Treatment, Outcomes(83), Protein Degradation and Inhibitors(81)

Publications994 total

Unsupervised machine learning reveals prognostic value of dynamic carbohydrate antigen 125 trajectory in gastric cancer
BMC Cancer·2025· 1 citedOpen Access
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience
Blood Cancer Journal·2025Open Access
Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025Open Access
Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
2025Open Access
Using single cell sequencing to investigate tumor microenvironment differences in left and right colon cancer and prognosis-related core genes
Discover Oncology·2025Open Access
Table S4 from Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
2025Open Access
Figure S1 from Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
2025Open Access
Figure S2 from Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
2025Open Access
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma
Blood Cancer Journal·2025Open Access
Why do drivers brake later than AEB in rear-end collisions? An analysis based on drive recorder videos
Accident Analysis & Prevention·2025Open Access
The Real‐World Safety and Efficacy of Bispecific T‐Cell Engager Therapy in Systemic <scp>AL</scp> Amyloidosis
American Journal of Hematology·2025· 1 cited
Table S7 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S9 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Figure S2 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S1 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S4 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S10 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S12 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Figure S1 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
Table S3 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
2025Open Access
page 1 of 50Next →

Frequent Co-authors

David Dingli(15), Francis K. Buadi(15), Angela Dispenzieri(15), Shaji Kumar(15), Morie A. Gertz(15), Martha Q. Lacy(15), Robert A. Kyle(14), Nelson Leung(14), Prashant Kapoor(14), John A. Lust(14), S. Vincent Rajkumar(14), Sattva S. Neelapu(13), Stephen J. Russell(13), Suzanne R. Hayman(12), Frederick L. Locke(11), Olalekan O. Oluwole(11), Steven R. Zeldenrust(11), David B. Miklos(10), Armin Ghobadi(10), Wilson I. Gonsalves(10)